Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

211
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
211
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

264
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
264
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

160
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
160
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

189
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
189
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction to: 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.

Circulation. Cardiovascular imaging·2026
Same author

Limitations of Risk and Symptom-Based Screening: Closing the Gap.

JACC. Advances·2026
Same author

15-Year Cardiovascular Risk in Patients With Angina Without Obstructive Coronary Arteries: Is the Answer Clear?

JACC. Cardiovascular interventions·2026
Same author

ACR Appropriateness Criteria® Evaluation of Cardiac Masses.

Journal of the American College of Radiology : JACR·2026
Same author

Preprocedural and Postprocedural CT Imaging Can Identify Patients at Risk for Complications After LAA Occlusion.

JACC. Advances·2026
Same author

Analysis of Closed Claims in Cardiovascular Medicine: Importance of Nonclinical Factors.

JACC. Advances·2026
Same journal

Sudden Cardiac Arrest and Takotsubo-Like Cardiomyopathy as the Initial Presentation of Primary Carnitine Deficiency.

JACC. Case reports·2026
Same journal

Secondary Cardiac Lymphoma Presenting as Effusive-Constrictive Pericarditis.

JACC. Case reports·2026
Same journal

Left Ventricular Outflow Tract Rupture in a Case of Pediatric Bicuspid Aortic Valve Endocarditis.

JACC. Case reports·2026
Same journal

Lyme Myopericarditis With Effusive-Constrictive Physiology: Serial CMR Identifies a Reversible Inflammatory Phenotype.

JACC. Case reports·2026
Same journal

Transcatheter Edge-to-Edge Repair of a Functionally Trileaflet Mitral Valve.

JACC. Case reports·2026
Same journal

Managing Rheumatic Mitral Stenosis Complicated by Shock and Cardiac Cirrhosis Beyond Guidelines.

JACC. Case reports·2026
查看所有相关文章

相关实验视频

Updated: Jan 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

辐射剂量优化在多中心CCTA计划中的辐射剂量优化

Rachel Roedding1, Juan Gaztanaga2, Shant Manoushagian3

  • 1Center for Cardiovascular Quality Transformation and Innovation and HeartHealth Program, Lee Health Heart Institute, Fort Myers, Florida, USA.

JACC. Case reports
|November 14, 2025
PubMed
概括
此摘要是机器生成的。

实施标准化冠状动脉计算机断层扫描血管学 (CCTA) 协议,在5家医院系统中,显著减少了23%的辐射剂量. 在不影响诊断质量的情况下,CCTA安全性得到了改善.

关键词:
(自由形式) 心脏CT剂量监测监测(自由形式) 多中心质量改进冠状动脉计算机断层扫描血管学 (CCTA)诊断图像质量 诊断图像质量协议标准化 协议标准化质量改善倡议 质量改善倡议辐射剂量优化辐射剂量优化

更多相关视频

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.7K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K

相关实验视频

Last Updated: Jan 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.7K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K

科学领域:

  • 心血管成像 - 心血管成像
  • 放射学 放射学是一门学科.
  • 医学物理 医学物理

背景情况:

  • 冠状动脉计算机断层扫描血管学 (CCTA) 将患者暴露在辐射中,增加终身癌症风险.
  • 一个5家医院的系统超过了最佳实践的辐射剂量目标,显示了设施间的显著变化.
  • 降低辐射剂量是CCTA中的一个关键的患者安全改善.

研究的目的:

  • 实施和评估标准化,基于证据的CCTA协议在一个多校区的卫生系统.
  • 为了减少辐射剂量,同时保持或改善诊断图像质量.
  • 在心血管成像中建立一个可扩展的剂量优化模型.

主要方法:

  • 全系统实施标准化的CCTA协议.
  • 利用持续的监测,员工教育和领导层参与协议的遵守.
  • 实施前和实施后的辐射剂量和诊断接受率的比较.

主要成果:

  • 中位辐射剂量减少了23% (从6.2mSv降至4.8mSv).
  • 诊断的接受度从90.5%提高到92.7% (P = 0.019).
  • 剂量减少在所有校园中都是一致的,无论设备的差异如何.

结论:

  • 标准化,基于证据的CCTA协议在减少各种临床环境中的辐射剂量方面是有效的.
  • 可以实现可持续的剂量减少,而不会对诊断质量产生负面影响.
  • 辐射剂量跟踪和协议标准化对于心血管成像中的患者安全至关重要.